News

Congratulations to Instant NanoBiosensors for being selected to participate in the incubator program held jointly by Merck Innovation Lab and H. Spectrum! Merck is a multinational pharmaceutical, chemical, and life sciences company while H. Spectrum is the startup platform established by Foxconn's Yonglin Healthcare Foundation. Partnership between the two focuses on solutions to improve patient care and precision medicine. Teams participating in the program will have the opportunity to interact with heads of different departments from Merck and even a chance to stay for three months at Merck Innovation Center to accelerate their growth.Related news: https://meet.bnext.com.tw/intl/articles/view/45133

Congratulations to Instant NanoBiosensors for being selected by Taiwan Startup Stadium as one of the five Taiwanese startups to attend the 2019 Techsauce Global Summit held in Bangkok, Thailand!Related news: https://meet.bnext.com.tw/intl/articles/view/45147https://techsauce.co/en/tech-and-biz/startups-from-taiwan-startup-stadium-participated-in-techsauce-global-summit/

Instant NanoBiosensors will be attending the 2019 TRANS Conference held on June 29th to 30th at National Taiwan University Sports Center in Taipei, Taiwan!Video about the 2019 TRANS Conference (Instant NanoBiosensors is at around 2:30) : https://youtu.be/3jwE82LI8mg

According to a report from PwC, the cost of healthcare in 2019 will grow by approximately 6%, continuing the predicted trend of 5.5%~7% from the previous five years. New forms of technology thus offer great potential to provide economical yet high quality healthcare to patients in need. At Instant NanoBiosensors, our state-of-the-art FOPPR technology enables ultrasensitive real-time detection of biomolecules, allowing for the early detection of diseases.Related news: Doctor in a Box

Congratulations to Instant NanoBiosensors for being invited to the 2018 BioGroup Symposium! The symposium encompassed topics from pharmaceutical development, artificial intelligence and precision medicine, cancer immunology and regnerative medicine, to challenges and opportunities for biotechnology in Taiwan, interactions between biotechnology societies around the globe, and investment profitability and global strategy, providing an opportunity for interactions between expertise from academia and industry.Related news: 年終最強生技人才交流— 2018 BioGroup Symposium 產學串聯 台灣起飛！